15 October 2025 in BMJ Open
Introduction Improving outcomes from sepsis in children is a WHO Global Health Priority, yet mortality from sepsis remains high, particularly in low- and middle-income countries (LMICs). This database from children with community-acquired childhood sepsis in LMICs and some high-income countries will allow analysis of the burden of disease, including incidence, severity and outcomes. Understanding these aspects of sepsis care is fundamental for the design and conduct of future international interventional trials to improve childhood sepsis outcomes. Methods and analysis This multicountry retrospective observational study will include children up to 18 years of age presenting to emergency departments with suspected sepsis, defined as admission to hospital for treatment with intravenous antibiotics plus (1) a provisional diagnosis of sepsis and/or (2) treatment for suspected sepsis (operationalised as the administration of one or more fluid bolus to treat impaired perfusion or vasoactive infusion). Presenting characteristics, management and outcomes will be collected. These will include vital signs, serum biomarkers, intravenous fluid administration for the first 24 hours of hospitalisation, organ support therapies delivered, antimicrobial use, microbiological diagnoses, hospital and intensive care unit length of stay, and mortality censored at hospital discharge or 30 days from enrolment (whichever occurs first). Ethics and dissemination Central ethics approval was received from the Royal Children’s Hospital of Melbourne, Australia Human Research Ethics Committee (HREC/100648/RCHM-2023). Each international site will be required to obtain local Institutional Research Ethics Board approval. The findings will be disseminated in peer-reviewed journals, at academic conferences and through lay media. A cleaned study database and individual site-level data will be made available to site investigators upon completion of the study. Trial registration number This study was registered with the Australian and New Zealand Clinical Trials Registry on 23 January 2024 prior to commencement of recruitment (ACTRN12624000052538).
12 June 2026 in JAIDS Journal of Acquired Immune Deficiency Syndromes
CPChatkamol Pheerapanyawaranun
Chatkamol Pheerapanyawaranun
OAon behalf of the TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
on behalf of the TREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
+15
Background: Transitioning from pediatric to adult HIV care is critical for adolescents and young adults living with HIV (AYLH). This study assessed the timing and factors associated with this transition in Asia. Setting: Retrospective study of AYLH enrolled in TREAT Asia Pediatric HIV Observational Database clinics between May 1991–December 2020. Methods: Eligible AYLH were categorized into 18-year-old transitions or continued pediatric care. Excluding AYLH who remained in pediatric care, median age at transition was 16.1 years (IQR: 14.9–17.0) for <18-year-old transitions and 20.0 years (IQR: 19.1–21.2) for ≥18-year-old transitions. At age 18, among 1,368 AYLH with available viral load data, 72.9% (n=998) had viral loads <50 copies/mL (78.9% in <18-year-old transitions [n=310/393] vs 70.6% in ≥18-year-old transitions [n=688/975]; P =0.002). Median CD4 count was 635 cells/μL (IQR: 450–842). Factors independently associated with transitions at ≥18 years old or continued pediatric care included residence in a high-middle-income country (aOR 10.68 [95%CI: 7.76, 14.68], P <0.001), living with family (aOR 2.81 [95%CI: 1.99, 3.97], P <0.001), and prior ART class switching (aOR 1.91 [95%CI: 1.34, 2.72], P <0.001). Conclusion: Most AYLH in this cohort transitioned at ≥18. About one-fourth had unsuppressed viral loads at age 18, irrespective of transition status, underscoring the need for personalized treatment approaches that support ART adherence from pediatric care, preparing AYLH for transition to adult clinics.
4 August 2026 in Journal of the Association of Nurses in AIDS Care
The aim of our study was to develop consensus from experts and advocates on the health care transition for young people living with HIV from pediatrics to adult care in Thailand using a modified Delphi method. Participants included physicians (58%), nurses (20%), clinic coordinators (11%), and outreach workers (11%). Survey items were distributed to gather responses. Consensus was achieved after two rounds of surveys (response rates: 86% and 94.5%, respectively). Key priorities identified included (1) pediatric clinics: early transition planning, individualized readiness assessment, and focusing on youth with an increased risk of poor treatment outcomes; (2) transition process: strong pediatric–adult clinic collaboration; (3) health care coverage scheme and system: making sure that youth are familiar with their resources and options; (4) adult clinics: providing communication skills training for providers aimed at offering youth-friendly, nonstigmatizing services; and (5) post-transition follow-up: communication to ensure a warm handoff. Effective transition care for young people living with HIV requires early preparation, sustained interclinic communication, and continuity-supportive care models.